Verition Fund Management’s Twist Bioscience TWST Stock Holding History
Bought
Maintained
Sold
Other funds holding TWST
AIM
EIG
VPM
VCM
Verition Fund Management's TWST Position: Q1 2026 in Review
Verition Fund Management opened a new position in Twist Bioscience (TWST) in Q1 2026: 20,670 shares worth $982K. The stake represents 0.01% of the portfolio and ranks #1310 among its holdings. This is a return to the name: Verition Fund Management previously reported a position in TWST as recently as Q3 2025.
Verition Fund Management first reported a position in TWST in Q1 2023 and has held it in 6 quarters since. The position peaked at $1.13M in Q3 2024. 279 funds tracked by Wall St. Rank hold TWST as of Q1 2026.
- Verition Fund Management held 20,670 shares of Twist Bioscience worth $982K as of Q1 2026.
- Twist Bioscience was a new Verition Fund Management position in Q1 2026.
- Twist Bioscience made up 0.01% of Verition Fund Management's portfolio in Q1 2026, its #1310 holding.
- Verition Fund Management first reported a position in Twist Bioscience in Q1 2023 and has held it in 6 quarters since.
- Verition Fund Management's Twist Bioscience position peaked at $1.13M in Q3 2024.
- 279 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2026.
Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.